Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myeloma. - Bal S; Htut M; Nadeem O; Anderson LD Jr; Gregory T; Kocoglu M; Rossi AC; Martin TG; Egan DN; Costa LJ; Hu H; Chen J; et al. (Blood, 2026)